- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 39/125 - Picornaviridae, e.g. calicivirus
Patent holdings for IPC class A61K 39/125
Total number of patents in this class: 295
10-year publication summary
|
14
|
12
|
24
|
28
|
14
|
21
|
13
|
23
|
24
|
11
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Vaccines, Inc. | 217 |
25 |
| Vactech Oy | 13 |
12 |
| Beijing Minhai Biotechnology Co., Ltd | 14 |
8 |
| Denka Company Limited | 2536 |
6 |
| Boehringer Ingelheim Animal Health USA Inc. | 416 |
6 |
| Boehringer Ingelheim Vetmedica, Inc. | 113 |
5 |
| Glaxosmithkline Biologicals S.A. | 1635 |
5 |
| Novartis Vaccines and Diagnostics, Inc. (a Delaware corporation) | 37 |
4 |
| Wisconsin Alumni Research Foundation | 3864 |
4 |
| The Trustees of the University of Pennsylvania | 4315 |
4 |
| Mayo Foundation for Medical Education and Research | 3191 |
4 |
| Children's Hospital Medical Center | 706 |
4 |
| Modernatx, Inc. | 1260 |
4 |
| Ip2ipo Innovations Limited | 171 |
4 |
| Duke University | 3063 |
3 |
| Icon Genetics GmbH | 46 |
3 |
| Lanzhou Veterinary Research Institute Chinese Academy of Agricultural Sciences | 30 |
3 |
| National Health Research Institutes | 323 |
3 |
| Quest Diagnostics Investments LLC | 396 |
3 |
| SENTINEXT THERAPEUTICS Sdn Bhd | 5 |
3 |
| Other owners | 182 |